Nivolumab in real-life clinical practice
Purpose of the study. To evaluate the efficacy and tolerability of nivolumab in oncologic patients in real-life clinical seffings.Patients and methods. Analysis included 114 patients aged 26-96 years with melanoma (n = 64), non-small cell lung carcinoma (NSCLC) (n = 37) and metastatic colorectal can...
Saved in:
Main Authors: | M. A. Lyadova, O. A. Pardabekova, R. R. Shakirov, V. K. Lyadov, M. Yu. Fedyanin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2019-12-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/463 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01) -
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study
by: Yuhei Kurata, et al.
Published: (2025-05-01) -
Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
by: Heves Surmeli, et al.
Published: (2025-06-01) -
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01) -
MODERN TREATMENT OF METASTATIC MELANOMA: FROM STANDARDS TO AN INDIVIDUALIZED APPROACH IN REAL CLINICAL PRACTICE
by: N. V. Zhukova, et al.
Published: (2018-06-01)